All Stories

  1. The spectrum of therapeutic activity of mepolizumab

    Article • Expert Review of Clinical Immunology, August 2019, Taylor & Francis

    Carlo Cavaliere, Eleni Makri

  2. Two decades with omalizumab: what we still have to learn

    Article • Biologics Targets and Therapy, October 2018, Dove Medical Press

    Eleni Makri

  3. When Allergen Immunotherapy Perfectly Meets its Need: A Case Report

    Article • Journal of Allergy & Therapy, January 2017, OMICS Publishing Group

    Eleni Makri

  4. Striving for optimal bronchodilation: focus on olodaterol

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2016, Dove Medical Press

    Eleni Makri

  5. New combinations in the treatment of COPD: rationale for aclidinium–formoterol

    Article • Therapeutics and Clinical Risk Management, February 2016, Dove Medical Press

    Eleni Makri

  6. New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]

    Article • Biologics Targets and Therapy, June 2015, Taylor & Francis

    Enrico Scala, Eleni Makri

  7. New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis

    Article • Biologics Targets and Therapy, September 2014, Taylor & Francis

    Enrico Scala, Eleni Makri

  8. Food Allergy as Defined by Component Resolved Diagnosis

    Article • Recent Patents on Inflammation & Allergy Drug Discovery, February 2014, Bentham Science Publishers

    Eleni Makri, Enrico Scala

  9. A Case of Apparent Contact Dermatitis Caused byToxocaraInfection

    Article • Case Reports in Dermatological Medicine, January 2014, Hindawi Publishing Corporation

    Eleni Makri

  10. Treating allergic rhinitis by sublingual immunotherapy: a review

    Article • Annali dell Istituto Superiore di Sanità, June 2012, Istituto Superiore di Sanita

    Eleni Makri